News & Events

News

All categories

Earnings

Press Release

All years

2019

2018

2017

2016

2015

2014

Affimed to Present at the 37th Annual J.P. Morgan Healthcare Conference

January 4, 2019

Affimed Announces U.S. Registrational Pathway and Updated Clinical Development Plan for AFM13 at R&D Day

December 7, 2018

Affimed Presents Data at ASH 2018 Substantiating Opportunity for AFM13 as Mono- and Combination Therapy in CD30-Positive Tumors

December 3, 2018

Affimed to Host Research & Development Day on Friday, December 7, 2018 in New York City

November 28, 2018

Affimed to Present at the Jefferies 2018 London Healthcare Conference

November 8, 2018

Affimed Reports Financial Results for Third Quarter 2018 and Operational Progress

November 7, 2018

Affimed Announces Oral Presentation and Five Poster Presentations at the 2018 American Society of Hematology Annual Meeting

November 1, 2018

Affimed Announces Third Quarter 2018 Financial Results and Corporate Update Conference Call on November 7, 2018

October 31, 2018

Affimed Places AFM11 (CD19/CD3-Targeting T cell Engager) Phase 1 Program on Clinical Hold

October 8, 2018

Affimed to Present at the 2018 Wells Fargo Securities Healthcare Conference

August 30, 2018

Affimed Announces Collaboration with Genentech to Develop Novel NK Cell Engager-based Immunotherapeutics for Multiple Cancer Targets

August 27, 2018

Affimed Reports Financial Results for Second Quarter 2018 and Operational Progress

August 8, 2018

Affimed Announces Second Quarter 2018 Financial Results and Corporate Update Conference Call

August 3, 2018

Affimed Announces Updated Data of AFM13 in Combination with Keytruda® (Pembrolizumab) in Patients with Relapsed/Refractory Hodgkin Lymphoma Presented at EHA

June 15, 2018

Affimed to Present at the Jefferies Global Healthcare Conference

May 30, 2018

Affimed Announces Annual General Meeting of Shareholders

May 18, 2018

Affimed Reports Financial Results for First Quarter 2018

May 15, 2018

Affimed Announces First Quarter 2018 Financial Results and Corporate Update Conference Call

May 8, 2018

Affimed to Present at Deutsche Bank's 43rd Annual Health Care Conference

May 3, 2018

Affimed Introduces ROCK™ Platform for Tailored Immune Cell Engagers

May 3, 2018

1
2
3
4
5
6
7

Events

All

Scientific

Investors

20Mar

Innate Killer Summit 2019

March 20 - 21, 2019 (San Diego, USA)
Presenter: Martin Treder

29Mar

AACR Annual Meeting 2019

March 29 - April 3, 2019 (Georgia, USA)

Webcasts of past events
All past events

We use cookies to give you the best experience on our website. By continuing to use it, you agree with it.